Europa Biosite is excited to announce the partnership of LubioScience and Axol Bioscience to distribute their portfolio in Switzerland.
With a mission to support the pursuit of more effective safer therapies, Axol Bioscience uses iPSCs to build better human disease models. Axol Bioscience have gained an international reputation for their production and characterisation of ‘excitable’ cells including CiPA-validated cardiomyocytes and neural stem cells from patients with neurological conditions including Alzheimer’s disease and Parkinson’s disease. Their portfolio includes human iPSC-derived cells, media products and contract services.
If you are interested in developing a partnership with any of the Europa Biosite subsidiaries, please do get in touch.
Partner with Europa Biosite
Europa Biosite partners with life science suppliers who share our values on quality, innovation and service.
If you are looking for a leading European distributor partner, we want to hear from you.